Recently published in The New England Journal of Medicine1 results of a phase 3, double-blind, randomized trial show that the…
NEJM
Approximately 70% of advanced breast cancers are hormone receptor-positive (HR+)/HER2-negative. Hormone therapies are widely used for the treatment of patients…
The New England Journal of Medicine publishes today the results of the SUNLIGHT study, a Phase III clinical trial comparing…
